Goldman Sachs (NYSE:GS) Stock Analyst Ratings

Goldman Sachs (NYSE:GS) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/30/2024 17.39% Morgan Stanley $333 → $449 Upgrades Equal-Weight → Overweight 01/18/2024 -5.88% BMO Capital $357 → $360 Maintains Market Perform 01/17/2024 15.03% JMP Securities → $440 Reiterates Market Outperform → Market Outperform 01/17/2024 28.37% Oppenheimer $481 → $491 Maintains Outperform 01/09/2024 15.03% UBS $382 → $440 Maintains Buy 01/09/2024 10.07% JP Morgan $398 → $421 Maintains Overweight 01/02/2024 28.89% Barclays $437 → $493 Maintains Overweight 12/04/2023 -12.94% Morgan Stanley $329 → $333 Maintains Equal-Weight 11/16/2023 22.35% Oppenheimer $447 → $468 Maintains Outperform 10/19/2023 16.86% Oppenheimer $450 → $447 Maintains Outperform 10/18/2023 15.03% JMP Securities → $440 Reiterates Market Outperform → Market Outperform 10/10/2023 15.03% JMP Securities $450 → $440 Maintains Market Outperform 10/03/2023 -13.99% Morgan Stanley $347 → $329 Maintains Equal-Weight 09/26/2023 17.65% Oppenheimer $461 → $450 Maintains Outperform 09/21/2023 […]

Goldman Sachs (NYSE:GS) Stock Analyst Ratings Read Post »

Pfizer’s Non-Covid Revenue Grew In 4Q And 2023

Pfizer’s 4Q revenue dropped 41% to $14.25B, below analyst forecasts, due to an expected decline in demand for its Covid-19 vaccine Comirnaty and Covid-19 treatment Paxlovid. Excluding those products, revenue was up 7% operationally, driven by new product launches and in-line product growth. The same trend followed for the full year, with 2023 revenue falling 42% overall but being up 8% when excluding Covid products. Pfizer is targeting operational revenue growth of 8% to 10% in 2024 when excluding Comirnaty and Paxlovid, as well as its Seagen subsidiary, though the company still expects to see about $8B in annual revenue from the two Covid products.

Pfizer’s Non-Covid Revenue Grew In 4Q And 2023 Read Post »

UPS to Cut 12,000 Jobs as Delivery Business Slows — WSJ

By Esther Fung United Parcel Service said Tuesday that it plans to cut about 12,000 jobs this year, a move that the package-delivery giant said would result in $1 billion in savings. Most of the cuts will be to full-time and part-time management positions and contract workers, and executives said they don’t expect these jobs to return when parcel volumes return. UPS has around 85,000 workers in management. Chief Executive Carol Tomé said that the company is using artificial intelligence and other new technologies to boost its operations. The job cuts were unveiled after the company said its revenue declined in the last quarter of 2023 as volumes in both its domestic and international businesses dropped. Write to Esther Fung at esther.fung@wsj.com

UPS to Cut 12,000 Jobs as Delivery Business Slows — WSJ Read Post »

Morgan Stanley Upgrades Bank of America, Goldman Sachs and Citi on ‘Lightened up’ Basel III Capital Requirements

By Steve Gelsi Analyst Betsy Graseck is ‘back & bullish’ on banks on sunnier prospects for a ‘significant increase in buybacks’ Morgan Stanley analyst Betsy Graseck on Tuesday upgraded Bank of America Corp., Goldman Sachs Group Inc., Citigroup Inc. and Bank of New York Mellon Corp. on optimism around pared-back capital requirements now under study by the the U.S. Federal Reserve. Morgan Stanley also said the entire group of big-bank stocks look attractive, and lifted price targets by a median of 16% across the board on 12 of them. If banks are not required to hold quite as much capital as in the initial Basel III endgame proposal by regulators, Graseck said it’s likely banks may boost moves to return money to shareholders. “Reading the tea leaves, it looks like Basel endgame will be lightened up,” Graseck said in a research note. “This opens the door for a significant increase

Morgan Stanley Upgrades Bank of America, Goldman Sachs and Citi on ‘Lightened up’ Basel III Capital Requirements Read Post »

Comcast (NASDAQ:CMCSA) Stock Analyst Ratings

Comcast (NASDAQ:CMCSA) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/30/2024 15.1% Citigroup $51 → $53 Maintains Buy 01/26/2024 8.59% Wells Fargo $45 → $50 Maintains Equal-Weight 12/22/2023 -0.1% Rosenblatt $44 → $46 Maintains Neutral 10/30/2023 -4.44% Barclays $47 → $44 Maintains Equal-Weight 10/27/2023 -4.44% Rosenblatt → $44 Reiterates Neutral → Neutral 10/27/2023 6.42% Scotiabank → $49 Downgrades Sector Outperform → Sector Perform 10/06/2023 15.1% Seaport Global → $53 Initiates Coverage On → Buy 09/25/2023 6.42% JP Morgan $48 → $49 Maintains Neutral 08/09/2023 8.59% Argus Research $45 → $50 Maintains Buy 08/02/2023 — Wolfe Research Upgrades Underperform → Peer Perform 08/01/2023 10.76% Citigroup $47 → $51 Maintains Buy 07/31/2023 -6.61% Rosenblatt $39 → $43 Maintains Neutral 07/31/2023 2.07% Barclays $42 → $47 Maintains Equal-Weight 07/28/2023 19.45% Oppenheimer $48 → $55 Maintains Outperform 07/28/2023 12.93% Morgan Stanley $50 → $52 Maintains Overweight

Comcast (NASDAQ:CMCSA) Stock Analyst Ratings Read Post »

Verizon Communications Inc. ((NYSE, NASDAQ:VZ) Stock Analyst Ratings

Verizon Communications Inc. ((NYSE, NASDAQ:VZ) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/30/2024 11.9% Citigroup $45 → $47 Maintains Buy 01/26/2024 4.76% Barclays $42 → $44 Maintains Overweight 01/25/2024 19.05% Tigress Financial $45 → $50 Maintains Buy 01/24/2024 2.38% UBS $37 → $43 Maintains Neutral 01/24/2024 4.76% Wells Fargo $40 → $44 Maintains Equal-Weight 01/24/2024 9.52% Raymond James $42 → $46 Maintains Outperform 01/24/2024 11.9% Daiwa Capital → $47 Upgrades Neutral → Outperform 01/24/2024 9.52% Keybanc $45 → $46 Maintains Overweight 01/04/2024 9.52% Wolfe Research → $46 Upgrades Peer Perform → Outperform 01/03/2024 7.14% Keybanc → $45 Upgrades Sector Weight → Overweight 12/19/2023 2.38% Oppenheimer → $43 Reiterates Outperform → Outperform 12/14/2023 -0% Citigroup $40 → $42 Maintains Buy 12/13/2023 -4.76% Wells Fargo $35 → $40 Maintains Equal-Weight 11/02/2023 7.14% Tigress Financial $64 → $45 Maintains Buy 10/25/2023 -9.52% Barclays $37

Verizon Communications Inc. ((NYSE, NASDAQ:VZ) Stock Analyst Ratings Read Post »

Pfizer Posts Surprise Fourth-Quarter Earnings Following Less-Than-Expected Paxlovid Course Returns

Pfizer (PFE) reported an unexpected fourth-quarter profit on Tuesday after the US government returned fewer doses of the pharmaceutical giant’s COVID-19 oral antiviral pill, Paxlovid, than previously expected. The company posted adjusted earnings of $0.10 a share for the December quarter, plummeting from $1.14 the year before. The consensus on Capital IQ was for a loss of $0.18. Revenue tumbled 41% to $14.25 billion, falling short of the Street’s view for $14.4 billion. Revenue from primary care, which includes the company’s Comirnaty COVID-19 vaccine and Paxlovid, slumped 60% to $6.99 billion. Paxlovid global revenue plunged by $5 billion due to a non-cash revenue reversal of $3.5 billion, related to the return of 6.5 million treatment courses from the government. The company estimated in October for a non-cash revenue reversal of $4.2 billion in the fourth quarter from the return of 7.9 million courses of the pill. Comirnaty global sales tumbled

Pfizer Posts Surprise Fourth-Quarter Earnings Following Less-Than-Expected Paxlovid Course Returns Read Post »

RTX’s Raytheon Says CHIMERA High-Power Microwave Weapon Field Test Completed in New Mexico

RTX’s (RTX) Raytheon unit said Monday it and the US Air Force Research Laboratory have completed a three-week field test of the CHIMERA high-power microwave weapon at White Sands Missile Range, New Mexico. CHIMERA stands for Counter-Electronic High-Power Microwave Extended-Range Air Base Defense system, the company said. The company added the system has been designed to fire highly concentrated radio energy at multiple middle-to-long-range targets. Raytheon has collaborated with the Air Force Research Laboratory, Naval Surface Warfare Center Dahlgren Division, and the Undersecretary of Defense for Research and Engineering to complete the project, the company said.

RTX’s Raytheon Says CHIMERA High-Power Microwave Weapon Field Test Completed in New Mexico Read Post »

Scroll to Top